Saturday, June 20, 2009

ASC and Leukemia

Interesting article at Science Daily.

Here, they are comparing the use of stem cells from the patient (nonallogeneic, or autologous) or from a donor (allogeneic). ESC are effectively always allogeneic.

The findings indicate that allogeneic treatments only benefit medium and high risk patients.

No comments: